Steven Feldman to Time Factors
This is a "connection" page, showing publications Steven Feldman has written about Time Factors.
Connection Strength
1.573
-
Alinia H, Tuchayi SM, James SM, Cardwell LA, Nanda S, Bahrami N, Awosika O, Richardson I, Huang KE, Feldman SR. Measurement of Disease Severity in a Population of Rosacea Patients. Dermatol Clin. 2018 Apr; 36(2):97-102.
Score: 0.103
-
Oussedik E, Patel NU, Cash DR, Gupta AS, Feldman SR. Severe and acute complications of biologics in psoriasis. G Ital Dermatol Venereol. 2017 Dec; 152(6):586-596.
Score: 0.101
-
Patel NU, D'Ambra V, Feldman SR. Increasing Adherence with Topical Agents for Atopic Dermatitis. Am J Clin Dermatol. 2017 Jun; 18(3):323-332.
Score: 0.099
-
Shaw MK, Davis SA, Fleischer AB, Feldman SR. The duration of office visits in the United States, 1993 to 2010. Am J Manag Care. 2014 Oct; 20(10):820-6.
Score: 0.082
-
Davis SA, Lin HC, Yu CH, Balkrishnan R, Feldman SR. Underuse of early follow-up visits: a missed opportunity to improve patients' adherence. J Drugs Dermatol. 2014 Jul; 13(7):833-6.
Score: 0.081
-
Huang KE, Carstensen SE, Feldman SR. The duration of acne treatment. J Drugs Dermatol. 2014 Jun; 13(6):655-6.
Score: 0.080
-
Ali ST, Feldman SR. Patient satisfaction in dermatology: a qualitative assessment. Dermatol Online J. 2014 Feb 18; 20(2).
Score: 0.079
-
Feldman SR, Winkelman W, Baum E, Preston N. Predicting improvement in signs and symptoms of plaque psoriasis after 1 week of treatment with clobetasol propionate 0.05% spray. J Drugs Dermatol. 2013 Dec; 12(12):1456-60.
Score: 0.078
-
Akamine KL, Gustafson CJ, Yentzer BA, Edison BL, Green BA, Davis SA, Feldman SR. A double-blind, randomized clinical trial of 20% alpha/poly hydroxy acid cream to reduce scaling of lesions associated with moderate, chronic plaque psoriasis. J Drugs Dermatol. 2013 Aug; 12(8):855-9.
Score: 0.076
-
Ahn CS, Awadalla F, Huang KE, Yentzer B, Dabade TS, Feldman SR. Patterns of vitamin D analog use for the treatment of psoriasis. J Drugs Dermatol. 2013 Aug; 12(8):906-10.
Score: 0.076
-
Davis SA, Feldman SR. Combination therapy for psoriasis in the United States. J Drugs Dermatol. 2013 May; 12(5):546-50.
Score: 0.074
-
Shah A, Yentzer BA, Feldman SR. Timing of return office visit affects adherence to topical treatment in patients with atopic dermatitis: an analysis of 5 studies. Cutis. 2013 Feb; 91(2):105-7.
Score: 0.073
-
Shah A, O'Neill J, Feldman SR. Treatment of moderate-to-severe psoriasis with alefacept for up to one year: a case series. J Drugs Dermatol. 2010 Dec; 9(12):1491-4.
Score: 0.063
-
Yentzer BA, Ade RA, Fountain JM, Clark AR, Taylor SL, Borgerding E, Feldman SR. Improvement in treatment adherence with a 3-day course of fluocinonide cream 0.1% for atopic dermatitis. Cutis. 2010 Oct; 86(4):208-13.
Score: 0.062
-
Balkrishnan R, Bhosle MJ, Camacho F, Fleischer AB, Feldman SR. Prescribing patterns for topical retinoids: analyses of 15 years of data from the national ambulatory medical care survey. J Dermatolog Treat. 2010 May; 21(3):193-200.
Score: 0.060
-
Feldman SR, Resneck JS. Commentary: The relative ease of obtaining a dermatologic appointment in Boston: how methods drive results. J Am Acad Dermatol. 2009 Jun; 60(6):949-50.
Score: 0.057
-
Thomas K, Yelverton CB, Yentzer BA, Balkrishnan R, Fleischer AB, Feldman SR. The cost-effectiveness of rosacea treatments. J Dermatolog Treat. 2009; 20(2):72-5.
Score: 0.055
-
Ziel K, Yelverton CB, Balkrishnan R, Feldman SR. Cumulative irritation potential of metronidazole gel compared to azelaic acid gel after repeated applications to healthy skin. J Drugs Dermatol. 2005 Nov-Dec; 4(6):727-31.
Score: 0.044
-
Vogel CA, Balkrishnan R, Fleischer AB, Cayce KA, Feldman SR. Over-the-counter topical skin products--a common component of skin disease management. Cutis. 2004 Jul; 74(1):55-67.
Score: 0.040
-
Feldman SR, Camacho F, Williford PM, Siegel DM, Balkrishnan R, Fleischer AB. Patients spend more time with the physician for excision of a malignant skin lesion than for excision of a benign skin lesion. Dermatol Surg. 2004 Mar; 30(3):351-3; discussion 353-4.
Score: 0.039
-
Lebwohl M, Sherer D, Washenik K, Krueger GG, Menter A, Koo J, Feldman SR. A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis. Int J Dermatol. 2002 May; 41(5):269-74.
Score: 0.035
-
Lim HW, Feldman SR, Van Voorhees AS, Gelfand JM. Recommendations for phototherapy during the COVID-19 pandemic. J Am Acad Dermatol. 2020 Jul; 83(1):287-288.
Score: 0.030
-
Papp KA, Krueger JG, Feldman SR, Langley RG, Thaci D, Torii H, Tyring S, Wolk R, Gardner A, Mebus C, Tan H, Luo Y, Gupta P, Mallbris L, Tatulych S. Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study. J Am Acad Dermatol. 2016 May; 74(5):841-50.
Score: 0.023
-
Davis SA, Feldman SR, Fleischer AB. Is the duration of skin disease visits decreasing in the United States? Dermatol Online J. 2014 Dec 13; 21(2).
Score: 0.021
-
Shaw M, Davis SA, Feldman SR, Fleischer AB. Decreasing frequency of office visits on fridays. J Dermatolog Treat. 2013 Dec; 24(6):405-7.
Score: 0.019
-
Kong MC, Camacho FT, Feldman SR, Anderson RT, Balkrishnan R. Correlates of patient satisfaction with physician visit: differences between elderly and non-elderly survey respondents. Health Qual Life Outcomes. 2007 Nov 24; 5:62.
Score: 0.013
-
Gordon KB, Feldman SR, Koo JY, Menter A, Rolstad T, Krueger G. Definitions of measures of effect duration for psoriasis treatments. Arch Dermatol. 2005 Jan; 141(1):82-4.
Score: 0.010